Carlos S.
- Country
- Spain
- Department
- Endocrinology and Nutrition
Research Overview
- Efficacy and Safety of Zenagamtide (NNC0487-0111) in Participants with Overweight or Obesity and Knee Osteoarthritis
- Phase 3 Randomized Double-Blind Placebo-Controlled Study of KAI-9531 in Adults With Obesity or Overweight and Diabetes
- Phase 3 Study of KAI-9531 in Adults With Obesity or Overweight With Weight-Related Comorbidities Without Diabetes
Data & Insights
Has run more than one trial at 39 of 134 partner sites.
Specializations
Diabetes Management
The investigator specializes in personalized treatment approaches for Type 2 Diabetes Mellitus, with particular emphasis on genetic-based therapeutic interventions. Their research explores how individual genetic profiles can influence diabetes control and treatment outcomes.
- Pharmacogenetic-guided therapy
- Diabetes control optimization
- Personalized medicine in diabetes
Endocrine Disorders
Focus areas include the treatment of chronic hypoparathyroidism, investigating novel therapeutic approaches through the study of eneboparatide. The research encompasses calcium homeostasis and vitamin D metabolism in endocrine conditions.
- Parathyroid hormone disorders
- Calcium metabolism
- Vitamin D supplementation
Metabolic Disorders
The investigator studies genetic variants related to obesity and their impact on body weight regulation. Their work includes research on targeted therapeutic approaches for genetic obesity and the role of metabolic signaling pathways.
- Genetic obesity management
- Weight control mechanisms
- Appetite regulation
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.